Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients

Transplantation

Volumn 95, Issue 3, 2013, Pages 470-478

  Morton, Muir ^a   Coupes, Beatrice ^a   Roberts, Stephen A ^b   Klapper, Paul E ^a,b   Byers, Richard J ^a   Vallely, Pamela J ^b   Ryan, Kate ^a   Picton, Michael L ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Epstein Barr virus; PTLD; Renal transplantation

Indexed keywords

ANTINUCLEAR ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNE DEFICIENCY; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERODIAGNOSIS; SKIN DISEASE; UNITED KINGDOM;

ADULT; AGED; ANTIBODIES, VIRAL; COHORT STUDIES; COMORBIDITY; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GREAT BRITAIN; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION;

EID: 84873406881     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318276a237     Document Type: Article

References (25)

1. Agraharkar ML, Cinclair RD, Kuo YF, et al. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int 2004; 66: 383.
2. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222.
3. Caillard S, Lelong C, Pessione F, et al. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry. Am J Transplant 2006; 6: 2735.
4. Faull RJ, Hollett P, McDonald SP. Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation 2005; 80: 193.
5. Libertiny G, Watson CJ, Gray DW, et al. Rising incidence of posttransplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001; 88: 1330.
6. Fernberg P, Edgren G, Adami J, et al. Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients. Am J Transplant 2011; 11: 2472.
7. Guppy AE, Rawlings E, Madrigal JA, et al. A quantitative assay for Epstein-Barr virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. Transplantation 2007; 84: 1534.
8. Macedo C, Donnenberg A, Popescu I, et al. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. Transpl Immunol 2005; 14: 109.
9. Smets F, Latinne D, Bazin H, et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002; 73: 1603.
10. Dolcetti R. B lymphocytes and Epstein-Barr virus: the lesson of posttransplant lymphoproliferative disorders. Autoimmun Rev 2007; 7: 96.
11. Capello D, Cerri M, Muti G, et al. Molecular histogenesis of post transplantation lymphoproliferative disorders. Blood 2003; 102: 3775.
12. Caillard S, Lamy FX, Quelen C, et al. Epidemiology of post transplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant 2012; 12: 682.
13. Opelz G, Daniel V, Naujokat C, et al. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation 2009; 88: 962.
14. Dharnidharka VR, Lamb KE, Gregg JA, et al. Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant 2012; 12: 976.
15. Quinlan SC, Pfeiffer RM, Morton LM, et al. Risk factors for earlyonset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol 2011; 86: 206.
16. ONS. Registrations of cancer diagnosed in 2008, England, Cancer statistics registrations. London, National Statistics, 2011.
17. Hummel M, Anagnostopoulos I, Dallenbach F, et al. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82: 689.
18. Hummel M, Anagnostopoulos I, Korbjuhn P, et al. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low-and high-grade types. J Pathol 1995; 175: 263.
19. Baker R, Jardine A, Andrews P. Post-operative care of the kidney transplant recipient. Renal Association Clinical Guidelines, 2011. www.renal.org/guidelines.
20. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9: S1
21. Holmes MV, Caplin B, Atkinson C, et al. Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil. Transplantation 2009; 87: 852.
22. Martin SI, Dodson B, Wheeler C, et al. Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients. Am J Transplant 2011; 11: 1058.
23. Morton M, Coupes B, Vallely P, et al. Increasing prevalence of EBV DNAemia with time from transplant in stable adult renal transplant recipients. Am J Transplant 2011; 11: 287.
24. Swerdlow S, Campo E, Harris N, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, IARC Press, 2008, p. 343.
25. NICE. Immunosuppressive therapy for renal transplantation in adults. Technol Appraisal 85. 2004.